Literature DB >> 22988868

LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease.

Yulan Xiong1, Valina L Dawson, Ted M Dawson.   

Abstract

Mutations in the LRRK2 (leucine-rich repeat kinase 2) gene are the most frequent genetic cause of PD (Parkinson's disease), and these mutations play important roles in sporadic PD. The LRRK2 protein contains GTPase and kinase domains and several protein-protein interaction domains. The kinase and GTPase activity of LRRK2 seem to be important in regulating LRRK2-dependent cellular signalling pathways. LRRK2's GTPase and kinase domains may reciprocally regulate each other to direct LRRK2's ultimate function. Although most LRRK2 investigations are centred on LRRK2's kinase activity, the present review focuses on the function of LRRK2's GTPase activity in LRRK2 physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988868      PMCID: PMC3701022          DOI: 10.1042/BST20120093

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  54 in total

1.  Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.

Authors:  Jan O Aasly; Carles Vilariño-Güell; Justus C Dachsel; Philip J Webber; Andrew B West; Kristoffer Haugarvoll; Krisztina K Johansen; Mathias Toft; John G Nutt; Haydeh Payami; Jennifer M Kachergus; Sarah J Lincoln; Amela Felic; Christian Wider; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Linda R White; Owen A Ross; Matthew J Farrer
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

2.  GTPase activity plays a key role in the pathobiology of LRRK2.

Authors:  Yulan Xiong; Candice E Coombes; Austin Kilaru; Xiaojie Li; Aaron D Gitler; William J Bowers; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

3.  LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.

Authors:  Javier Alegre-Abarrategui; Helen Christian; Michele M P Lufino; Ruxandra Mutihac; Lara Lourenço Venda; Olaf Ansorge; Richard Wade-Martins
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

4.  Identification of the autophosphorylation sites of LRRK2.

Authors:  Shogo Kamikawaji; Genta Ito; Takeshi Iwatsubo
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

5.  Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.

Authors:  Saurabh Sen; Philip J Webber; Andrew B West
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

Review 6.  LRRK2 in Parkinson's disease: genetic and clinical studies from patients.

Authors:  Udhaya Kumari; E K Tan
Journal:  FEBS J       Date:  2009-10-05       Impact factor: 5.542

7.  Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

Authors:  Christian Johannes Gloeckner; Karsten Boldt; Felix von Zweydorf; Sandra Helm; Ludwig Wiesent; Hakan Sarioglu; Marius Ueffing
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

8.  Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice.

Authors:  Youren Tong; Hiroo Yamaguchi; Emilie Giaime; Scott Boyle; Raphael Kopan; Raymond J Kelleher; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

9.  R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.

Authors:  Youren Tong; Antonio Pisani; Giuseppina Martella; Maha Karouani; Hiroo Yamaguchi; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

10.  Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Authors:  Byoung Dae Lee; Joo-Ho Shin; Jackalina VanKampen; Leonard Petrucelli; Andrew B West; Han Seok Ko; Yun-Il Lee; Kathleen A Maguire-Zeiss; William J Bowers; Howard J Federoff; Valina L Dawson; Ted M Dawson
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

View more
  12 in total

1.  Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.

Authors:  Md Shariful Islam; Hendrik Nolte; Wright Jacob; Anna B Ziegler; Stefanie Pütz; Yael Grosjean; Karolina Szczepanowska; Aleksandra Trifunovic; Thomas Braun; Hermann Heumann; Rolf Heumann; Bernhard Hovemann; Darren J Moore; Marcus Krüger
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

Review 2.  Models of LRRK2-Associated Parkinson's Disease.

Authors:  Yulan Xiong; Ted M Dawson; Valina L Dawson
Journal:  Adv Neurobiol       Date:  2017

3.  Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease.

Authors:  Ken Y Hui; Heriberto Fernandez-Hernandez; Jianzhong Hu; Adam Schaffner; Nathan Pankratz; Nai-Yun Hsu; Ling-Shiang Chuang; Shai Carmi; Nicole Villaverde; Xianting Li; Manual Rivas; Adam P Levine; Xiuliang Bao; Philippe R Labrias; Talin Haritunians; Darren Ruane; Kyle Gettler; Ernie Chen; Dalin Li; Elena R Schiff; Nikolas Pontikos; Nir Barzilai; Steven R Brant; Susan Bressman; Adam S Cheifetz; Lorraine N Clark; Mark J Daly; Robert J Desnick; Richard H Duerr; Seymour Katz; Todd Lencz; Richard H Myers; Harry Ostrer; Laurie Ozelius; Haydeh Payami; Yakov Peter; John D Rioux; Anthony W Segal; William K Scott; Mark S Silverberg; Jeffery M Vance; Iban Ubarretxena-Belandia; Tatiana Foroud; Gil Atzmon; Itsik Pe'er; Yiannis Ioannou; Dermot P B McGovern; Zhenyu Yue; Eric E Schadt; Judy H Cho; Inga Peter
Journal:  Sci Transl Med       Date:  2018-01-10       Impact factor: 17.956

4.  68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment.

Authors:  Joseph M Thomas; Tianxia Li; Wei Yang; Fengtian Xue; Paul S Fishman; Wanli W Smith
Journal:  Front Aging Neurosci       Date:  2017-01-10       Impact factor: 5.750

5.  GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.

Authors:  Marian Blanca Ramírez; Antonio Jesús Lara Ordóñez; Elena Fdez; Jesús Madero-Pérez; Adriano Gonnelli; Matthieu Drouyer; Marie-Christine Chartier-Harlin; Jean-Marc Taymans; Luigi Bubacco; Elisa Greggio; Sabine Hilfiker
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

Review 6.  Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?

Authors:  Yulan Xiong; Jianzhong Yu
Journal:  Front Neurol       Date:  2018-04-09       Impact factor: 4.003

7.  Inflammatory Bowel Diseases and Parkinson's Disease.

Authors:  Tomasz Brudek
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

8.  Genetic insights into sporadic Parkinson's disease pathogenesis.

Authors:  Chou Chai; Kah-Leong Lim
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 9.  LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  J Neuroinflammation       Date:  2014-03-21       Impact factor: 8.322

10.  Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.

Authors:  Francesco Longo; Isabella Russo; Derya R Shimshek; Elisa Greggio; Michele Morari
Journal:  Neurobiol Dis       Date:  2014-08-06       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.